A phase I trial of MW-001 for the treatment of multiple sclerosis
Latest Information Update: 09 Aug 2016
Price :
$35 *
At a glance
- Drugs MW 001 (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 09 Aug 2016 New trial record
Latest Information Update: 09 Aug 2016